BioCentury
ARTICLE | Company News

Verus Pharma, Paladin sales and marketing update

August 1, 2005 7:00 AM UTC

Verus granted PLB exclusive commercialization rights in Canada to its Twinject epinephrine auto-injector. The product is approved as an emergency treatment for severe allergic reactions (anaphylaxis)....